Unveiling ResMed (RMD) Q1 Outlook: Wall Street Estimates for Key Metrics
Analysts on Wall Street project that ResMed (RMD) will announce quarterly earnings of $2.03 per share in its forthcoming report, representing an increase of 23.8% year over year. Revenues are projected to reach $1.19 billion, increasing 7.9% from the same quarter last year. The consensus EPS estima...